IPCA Laboratories share news and announcements
NSE: IPCALABBSE: 524494Pharmaceuticals & BiotechnologyMid Cap
Last close ₹1,953.30up ₹49.80 (2.62%)BSE ₹1,951.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,903.50.
52-week range of traded prices to 23 Oct 2026
₹1,251.60Low, 24 Oct 2025₹2,038.00High, 18 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹49,556 Cr229th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 37.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 6.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.31%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 17.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 17.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,18,78151.9% delivered
IPCA Laboratories board meetings
123 filed, newest first. Page 1 of 3.
Oct 2026
Jul 2026
Jun 2026
26 Jun · Board meeting
May 2026
Jan 2026
13 Jan · Board meeting
Oct 2025
17 Oct · Board meeting
Jul 2025
May 2025
Mar 2025
28 Mar · Board meeting
Feb 2025
13 Feb · Board meeting
Jan 2025
Nov 2024
14 Nov · Board meeting
Oct 2024
Sep 2024
30 Sep · Board meeting
Aug 2024
13 Aug · Board meeting
Jul 2024
May 2024
29 May · Board meeting
Feb 2024
14 Feb · Board meeting
Jan 2024
Nov 2023
10 Nov · Board meeting
Oct 2023
Aug 2023
10 Aug · Board meeting
Jul 2023
May 2023
29 May · Board meeting
Apr 2023
24 Apr · Board meeting
Jan 2023
Nov 2022
Oct 2022
Jul 2022
May 2022
Feb 2022
14 Feb · Board meeting
Jan 2022
Dec 2021
Nov 2021
24 Nov · Board meeting
Oct 2021
Aug 2021
Jul 2021
May 2021
28 May · Board meeting
28 May · Board meeting
Feb 2021
4 Feb · Board meeting
Jan 2021
Oct 2020
Sep 2020
2 Sep · Board meeting